PROMPT DIAGNOSTICS, INC.

Medtech · Private

Automated point-of-care diagnostic device with magnetic particle-enabled assays in a multiplexed cartridge for rapid detection of Treponema pallidum infection

Grants
$2.0M
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$543K
2 awards · Health and Human S
#379 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Portable magnetofluidic platform for rapid multiplexed detection of sexually transmitted infections$258,558
Federal contractDepartment of Health and Human Services · Rapid Detection Device For C Auris$243,179
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Hybrid DNA-protein quantification platform for point-of-care diagnosis of syphilis and human immunodeficiency viruses (HIV)$255,667
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Hybrid DNA-Protein Quantification Platform for Point-of-Care Diagnosis$1,250,000
Federal contractDepartment of Health and Human Services · Prompt Point-of-care Hiv Viral Load Monitoring$300,000
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
376NELSON SCIENTIFIC LABS LLC$570K—
377Spectradyne LLC$553K—
378Oxford Performance Materials, Inc.$547K$46M
379PROMPT DIAGNOSTICS, INC.$543K—
380ANTIMICROBIAL MATERIALS INC$538K—
381RPRD Diagnostics, LLC$521K—
382BARRETT TECHNOLOGY, LLC$505K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.